Fisher & Paykel HealthcareFSPKF +9.59%90 Days Payable is 68.32 as of Mar. 2026, which is 114% above its 10-year median of 31.88. GuruFocus rates FSPKF with a GF Score™ of 90/100 and a GF Value™ of $27.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks worse than 62.77% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Days Payable falls into.
Fisher & Paykel Healthcare Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (FSPKF) has a Days Payable of 68.32 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fisher & Paykel Healthcare and its competitors. This is 114% above median its historical median of 31.88. Over the past decade, Fisher & Paykel Healthcare's Days Payable has ranged from 19.70 to 54.77. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #499 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 62.8%.
Is Fisher & Paykel Healthcare's Days Payable too high?
Fisher & Paykel Healthcare's current Days Payable of 68.32 is 114% above median its 10-year median of 31.88. Over the past 10 years, this metric has ranged from a low of 19.70 to a high of 54.77. The Medical Devices & Instruments industry median Days Payable is 67.87. Fisher & Paykel Healthcare's value of 68.32 is 0.7% above this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #499 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fisher & Paykel Healthcare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #499 out of 795 companies for Days Payable. This places Fisher & Paykel Healthcare in the lower half of its industry. The industry median Days Payable is 67.87. Fisher & Paykel Healthcare's value of 68.32 is 0.7% above this benchmark. Historically, Fisher & Paykel Healthcare's own Days Payable has ranged from 19.70 to 54.77 over the past decade. While the company's 10-year median is 31.88 vs. the industry median of 67.87, Fisher & Paykel Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current Days Payable of 68.32 is 0.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current Days Payable is 68.32, which is 114% above median its own 10-year median of 31.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (FSPKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $27.38, compared to a current price of $22.52 — trading 17.8% below its estimated fair value. The current Days Payable is 68.32, which is 114% above median its 10-year median of 31.88 and 0.7% above the Medical Devices & Instruments industry median of 67.87. Fisher & Paykel Healthcare's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FSPKF), the current Days Payable is 68.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (FSPKF) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of $22.52 is trading 17.8% below its estimated GF Value™ of $27.38.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for FSPKF:
Days Payable: 68.32 (114% above median its 10-year median of 31.88)
GF Value™: $27.38 vs. price of $22.52 (17.8% below fair value)
Industry Position: 0.7% above the Medical Devices & Instruments median (#499 of 795)
No single metric tells the full story. See the FSPKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
90GF Score
Get the complete analysis for FSPKF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSPKF has been successfully added to your 
